Navigation Links
Interventional Cardiologists Cautious in Adopting Intravascular Imaging and Assessment Devices: Challenge to Manufacturers
Date:2/7/2013

TORONTO, Feb. 7, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, interventional cardiologists looking for ways to improve outcomes and avoid unnecessary revascularization procedures are looking carefully at the available clinical evidence supporting the use of intravascular and assessment devices. These physicians see the value in fractional flow reserve (FFR) pressure guidewires, but are more reluctant to adopt optical coherence catheters (OCT) and intravascular ultrasound (IVUS).

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO )

Interventional cardiologists see these methods as a way to improve clinical outcomes, more accurately assess which vessel blockages actually require intervention, reduce 30-day readmissions and treat more patients with optimal medical therapy (OMT).

"This is a dynamic market and physicians are anxious to make decisions based on the best clinical data," said MRG Analyst Ian Swanson . "Many have not settled on a favored modality for assessing lesions. The tight budgets means that not only will OCT and IVUS will be competing directly with each other, and it's likely that physicians will favor one or the other, but that these modalities will be competing with FFR, which has the strongest clinical data. This survey gives an unequalled view of the attitudes of those directly involved in purchase decisions."

FFR will see the largest increase in market penetration, as physicians increasingly use pressure guidewires to determine which lesions require revascularization. The higher-cost OCT and IVUS have less clinical evidence supporting their use. Manufacturers without an FFR product will find themselves squeezed by competitors.

Physicians also pointed out what they saw as unmet needs in this market, which include better integration into the cath lab; single "one-stop" modalities; better non-invasive imaging and most importantly, lower-cost devices.

These results come from a new MRG survey, Intravascular Imaging and Assessment: Is Seeing Believing?, part of its Physician Forum series. Physician Forum surveys are produced in response to specific market events and trends that are expected to have significant effects on the utilization and sales of medical devices. This survey was published in December 2012.

The results are based on surveys that were conducted in November 2012 and included 77 respondents. They were interventional cardiologists, including both users and nonusers of vascular imaging and lesion assessment technologies.

Millennium Research Group's Intravascular Imaging and Assessment: Is Seeing Believing? survey provides information about physician attitudes and purchase decision criteria for fractional flow reserve (FFR) pressure guidewires, optical coherence catheters (OCT) and intravascular ultrasound (IVUS) devices as well as new modalities such as near-infrared spectroscopy (NIRS), instantaneous wave free ratio (iFR) and fractional flow reserve from computed tomography (FFRCT).

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:Christopher Comfort

Alex JablokowDecision Resources, Inc.

Millennium Research Group781-993-2597

617-599-8613ccomfort@dresources.com 

ajablokow@mrg.net 


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The American Society of Interventional Pain Physicians Announces Guidelines for Responsible Prescribing of Pain-Killers for Chronic Non-Cancer Pain
2. North America Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others
3. Brazil Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others
4. Interventional Spine Announces its 75th Patient Treated with the PerX360 Percutaneous Spinal Fusion Technology
5. Philips and Corindus announce distribution agreement to sell Corindus robotic-assisted interventional cardiology system in the United States
6. Philips and Biocompatibles Team-up to Advance Image Guided Transarterial Embolizations in Interventional Oncology
7. U.S. Market for Interventional Cardiology Devices
8. Arbor Pharmaceuticals partners with the Association of Black Cardiologists to further the campaign of "Saving Hearts of a Diverse America"
9. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
10. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
11. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):